AIT Therapeutics to Participate in the JMP Securities Life Science Conference
June 15, 2017 16:15 ET
|
AIT Therapeutics, Inc.
REHOVOT, Israel and NEW YORK, June 15, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide...
AIT Therapeutics Announces Appointment of Steve Lisi as Chief Executive Officer
June 14, 2017 08:00 ET
|
AIT Therapeutics, Inc.
REHOVOT, Israel and NEW YORK, June 14, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases with nitric oxide...
AIT Therapeutics Inc. Raises Gross Proceeds of $10.9 Million and Completes Reverse Merger
April 04, 2017 16:01 ET
|
AIT Therapeutics, Inc.
REHOVOT, Israel and NEW YORK, April 04, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical stage anti-microbial therapeutic company treating respiratory diseases, today announced...
AIT Therapeutics Inc. Appoints Hai Aviv as Chief Financial Officer
February 01, 2017 08:00 ET
|
AIT Therapeutics, Inc.
REHOVOT, Israel and NEW YORK, Feb. 01, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics INC (OTC:KKIC), a leading anti-microbial therapeutic company, today announced the appointment of Hai Aviv as the...